« Back to Record
Snoeck, R., Andrei, G., Bodaghi, B., Lagneaux, L., Daelemans, D., de Clercq, E., Neyts, J., Schols, D., Naesens, L., Michelson, S., Bron, D., Otto, M. J., Bousseau, A., Nemecek, C., & Roy, C. (2002). 2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. Antiviral research, 55(3), 413-424. doi:10.1016/S0166-3542(02)00074-8
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/89851



